{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04141",
      "entity_text" : "CSF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01178",
      "entity_text" : "OXT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In conclusion, to our knowledge this is the first study that provides evidence that intranasally administered OXT elevates OXT concentrations in human plasma and CSF and that kinetics of changes in these compartments are different.",
  "reading_complete" : "2020-08-04T12:11:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:09:57Z",
  "trigger" : "elevates",
  "evidence" : [ "OXT elevates OXT concentrations in human plasma and CSF" ],
  "pmc_id" : "3853684",
  "score" : 0
}